<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients with pediatric <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (PSLE) and <z:hpo ids='HP_0001973'>autoimmune thrombocytopenia</z:hpo> (AT), who developed unacceptable side effects (<z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, excessive <z:mp ids='MP_0005456'>weight gain</z:mp>) from treatment with steroids, were treated successfully with <z:chebi fb="0" ids="28445">vincristine</z:chebi> (2 patients) or intravenous immunoglobulin (1 patient) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients remained off steroids without any complications for 11 to 23 months </plain></SENT>
</text></document>